These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23238270)

  • 1. Heparin-induced hemorrhagic blisters.
    Roux J; Duong TA; Ingen-Housz-Oro S; Valeyrie-Allanore L; Ortonne N; Chosidow O; Wolkenstein P
    Eur J Dermatol; 2013; 23(1):105-7. PubMed ID: 23238270
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare cutaneous manifestation of hemorrhagic bullae to low-molecular-weight heparin and fondaparinux: report of two cases.
    Komforti MK; Bressler ES; Selim MA; Bressler GS; Ortel TL
    J Cutan Pathol; 2017 Jan; 44(1):104-106. PubMed ID: 27766660
    [No Abstract]   [Full Text] [Related]  

  • 3. Type I and Type IV allergy to unfractionated heparin and low-molecular-weight heparin with no reaction to recombinant hirudin.
    Hallai N; Hughes TM; Stone N
    Contact Dermatitis; 2004 Sep; 51(3):153-4. PubMed ID: 15479209
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced skin necrosis and low molecular weight heparins.
    Drew PJ; Smith MJ; Milling MA
    Ann R Coll Surg Engl; 1999 Jul; 81(4):266-9. PubMed ID: 10615196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous hemorrhagic dermatosis distant from the site of heparin injection.
    Concha-Garzon M; Sotomayor-Lopez E; Solano-Lopez G; Fraga J; De Argila D
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous hemorrhagic dermatosis at distant sites: a report of 2 new cases due to enoxaparin injection and a review of the literature.
    Villanueva CA; Nájera L; Espinosa P; Borbujo J
    Actas Dermosifiliogr; 2012 Nov; 103(9):816-9. PubMed ID: 22341878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-Induced Bullous Hemorrhagic Dermatosis: A Report of an Exceptionally Exuberant Case and Literature Review.
    Cortez de Almeida RF; Vita Campos C; Daxbacher EL; Jeunon T
    Am J Dermatopathol; 2021 Jul; 43(7):497-505. PubMed ID: 33795557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity].
    Thuillier D; Chaby G; Dadban A; Dascotte E; Miquel-Christophe O; Andrejak M; Chatelain D; Lok C
    Ann Dermatol Venereol; 2009 Oct; 136(10):705-8. PubMed ID: 19801254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bullous hemorrhagic dermatosis induced by heparin: description of 2 new cases].
    Loidi Pascual L; Valcayo Peñalba A; Yerani Ruiz de Azúa Ciria A; Yanguas Bayona I
    Med Clin (Barc); 2014 Dec; 143(11):516-7. PubMed ID: 24636015
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
    Schapkaitz E; Jacobson BF
    S Afr Med J; 2007 Dec; 97(12):1255-7. PubMed ID: 18271118
    [No Abstract]   [Full Text] [Related]  

  • 11. Low molecular weight heparins and bleeding.
    Breddin HK
    Semin Thromb Hemost; 1989 Oct; 15(4):401-4. PubMed ID: 2479104
    [No Abstract]   [Full Text] [Related]  

  • 12. Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin.
    Kavanagh D; Hill AD; Martin S; Power C; McDermott EW; O'Higgins N; Murphy K
    Thromb Haemost; 2004 Apr; 91(4):833-4. PubMed ID: 15045154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe hemorrhagic complications during treatment with low molecular weight heparin. Apropos of 2 cases].
    Grateau G; Chauvenet L; Oudard S; Bachmeyer C; Capron L; Horellou MH; Samama MM
    Rev Med Interne; 1997; 18(5):411-5. PubMed ID: 9183451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal subdural haematoma: a rare complication of low-molecular-weight heparin therapy.
    Chau SY; Tiu SC
    Hong Kong Med J; 2008 Feb; 14(1):64-6. PubMed ID: 18239247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous hypersensitivity reaction to enoxaparin].
    Córdoba López A; Bueno Alvarez-Arenas MI; Monterrubio Villar J; Corcho Sánchez G
    Med Clin (Barc); 2001 Oct; 117(12):478-9. PubMed ID: 11674977
    [No Abstract]   [Full Text] [Related]  

  • 16. Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE.
    Lassen MR; Fisher W; Mouret P; Agnelli G; George D; Kakkar A; Mismetti P; Turpie AG;
    J Thromb Haemost; 2012 May; 10(5):822-32. PubMed ID: 22429800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin and fibrinolysis: ExTRACTing prognosis from bleeding complications.
    Sinnaeve P; Van de Werf F
    Eur Heart J; 2010 Sep; 31(17):2077-9. PubMed ID: 20525980
    [No Abstract]   [Full Text] [Related]  

  • 18. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
    Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
    Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin hemorrhagic bullae induced by enoxaparin.
    Torres-Navarro I; de Unamuno-Bustos B; Pujol-Marco C
    Med Clin (Barc); 2021 Jan; 156(1):42-43. PubMed ID: 31784110
    [No Abstract]   [Full Text] [Related]  

  • 20. [A necrotic plaque on the thigh].
    Roth B; Debarbieux S; Causeret AS; Trzeciak MC; Claudy A
    Ann Dermatol Venereol; 2003 Nov; 130(11):1061-3. PubMed ID: 14724545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.